PATH vs TSE · P/E 19, rev $1.61B vs rev $3.51B
Uipath Inc (PATH) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. TSE currently screens at market cap $8.3M.
Not investment advice. Open the PATH and TSE stock pages for the full models.
Not investment advice.